Transcend Capital Advisors’s BioAtla BCAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-10,000
Closed -$17.6K 575
2024
Q3
$17.6K Buy
+10,000
New +$17.6K ﹤0.01% 615
2023
Q3
Sell
-49,000
Closed -$147K 491
2023
Q2
$147K Buy
+49,000
New +$147K 0.01% 466